Melatonin administration elevates miR-16-5p expression, which can specifically target SMAD3 with negative regulation on its abundance, highlighting that miR-16-5p/SMAD3 interactions have important effects on melatonin-induced growth defects within GC [16]. This evidence concerns the gene SMAD3 and gastric cancer.